Loading...

NEXTGEN SARCOMA MUTATION BASIC PANEL

image not found

NABL Cap Accredited 
The NextGen Sarcoma Mutation Basic Panel at Metropolis Healthcare is a focused genomic test designed to detect key mutations associated with various soft tissue and bone sarcomas. This panel evaluates essential cancer-related genes using high-depth Next-Generation Sequencing to support accurate diagnosis and targeted treatment planning. Metropolis Healthcare ensures precise molecular insights through advanced sequencing technology and stringent quality standards. It is suitable for patients with suspected or confirmed sarcoma requiring molecular characterization for therapy selection.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 16,000.00

Sample Type: Tissue

Fasting Not Required


Notes:N8208

Frequently Asked Questions (FAQ's):

What does the NextGen Sarcoma Mutation Basic Panel at Metropolis Healthcare include?
It analyzes essential sarcoma-associated genes to detect mutations relevant for diagnosis and treatment planning.

How does Metropolis Healthcare perform this sarcoma mutation panel?
Metropolis Healthcare uses high-depth NGS platforms and validated bioinformatics tools for accurate mutation detection.

Who should consider taking this test at Metropolis Healthcare?
Patients with suspected or confirmed soft tissue or bone sarcomas needing molecular profiling should consider this test.

Is fasting required for this genetic test at Metropolis Healthcare?
No fasting is required; the test uses tumor tissue samples as recommended by the clinician.

How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to detailed sequencing and variant interpretation.

Can this test at Metropolis Healthcare help in selecting targeted therapies?
Yes, detected mutations can guide eligibility for specific targeted or precision-based treatments.

How accurate is the mutation analysis conducted by Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through deep sequencing coverage and strict quality control protocols.

Does this panel help with long-term sarcoma management at Metropolis Healthcare?
Yes, the molecular insights support personalized treatment strategies and ongoing clinical decision-making.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab